As state and federal lawmakers examine public health policies surrounding botanical products, understanding the distinction between natural kratom and engineered synthetic compounds is critical. In this brief, Mac Haddow, Senior Fellow on Public Policy at the American Kratom Association (AKA), outlines why blanket prohibition creates enforcement blind spots and how modern consumer protection standards can effectively protect the public while maintaining access to pure, natural botanicals. KEY TOPICS DISCUSSED:
- The Regulatory Precedent: Lessons from the hemp and synthetic cannabinoid markets.
- Natural Kratom vs. Synthetic 7-OH: Understanding alkaloid ratios and engineered concentrations.
- The Risk of Category Collapse: Why broad bans harm consumers and fail to stop illicit synthetic markets.
- Comprehensive Policy Solutions: Actionable regulatory tools including product registration, age restrictions, independent laboratory testing, and clear synthetic exclusions.
